Evaluating the benefits of an antihypertensive agent using t... : Journal of Hypertension
Evaluating the benefits of an antihypertensive agent using trials based on event and organ …

The pharmacologic goals of long-acting calcium (Ca) antagonists are to obtain effective drug
concentrations with low interdose fluctuations and therefore a more efficacious hypotensive …

Aim: To compare the vascular effects of lacidipine with those of other calcium antagonists.
Methods: A review of published studies. Results: Experimental studies have shown that for a …

1. The aim of this randomised, double‐blind four way crossover study was to assess the
interaction between the new calcium antagonist, lacidipine and atenolol, in patients with …

Lacidipine is a second-generation 1.4-dihydropyridine calcium antagonist, whose potent
and long-lasting antihypertensive properties prompted us to investigate whether its chronic …

The evaluation of haemodynamic patterns in hypertensive patients by radionuclide
techniques and a tomographic gamma camera has revealed differences between older and …

In the treatment of hypertension, some patients may go off control while still on the drugs.
This occurs especially with sympathetic inhibitors and vasodilators. Lacidipine, a new …

This randomised, double-blind, double-dummy, parallel group, multicentre study compared
the efficacy and tolerability of lercanidipine with lacidipine. Elderly patients with isolated …

Arterial hypertension is a chronic condition regarded as one of the main risk factors for
development of coronary atherosclerosis. As dyslipidemia and reduced glucose tolerance …